RNAi Roundup: CytRx Names Full-time CFO; Genta to Enter RNAi Arena with Salus Acquisition; Nucleonics licenses RNAi Patent Applications from Wyeth; EURIT Sets Meeting for September 2 | GenomeWeb

NEW YORK, Aug. 22 (GenomeWeb News) - A year after it merged with Global Genomics, CytRx has found a permanent chief financial officer in Kirk Peacock, 35, who on Aug. 15 took the company's fiscal reins from interim-CFO and still-CEO Steve Kriegsman.   

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

HHS Secretary Tom Price says the NIH budget contains unneeded expenses that can be trimmed, Stat News reports.

The chair of the House science committee says the journal Science is not objective, the Huffington Post reports.

In Nature this week: glioma GWAS uncovers new risk loci, and more.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.